50419-395 : Nubeqa 300 mg Oral Tablet, Film Coated
| NDC: | 50419-395 |
| Labeler: | Bayer Healthcare Pharmaceuticals Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Nubeqa |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA212099 |
| Rev. Date: |
Appearance:
| Markings: | 300;Bayer |
| Shapes: |
Oval |
| Colors: |
 White |
| Size (mm): | 16 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 50419-395-01: 1 BOTTLE IN 1 CARTON (50419‑395‑01) > 120 TABLET, FILM COATED IN 1 BOTTLE
- 50419-395-72: 1 BOTTLE IN 1 CARTON (50419‑395‑72) > 120 TABLET, FILM COATED IN 1 BOTTLE
Active Ingredients:
- Darolutamide
Dosage Strength:
- 300 mg
Inactive Ingredients:
- Anhydrous Dibasic Calcium Phosphate
- Croscarmellose Sodium
- Lactose Monohydrate
- Magnesium Stearate
- Povidone K30
- Polyethylene Glycol 3350
- Titanium Dioxide /
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50419-393Next: 50419-402 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.